Human-Induced Pluripotent Stem Cells (hiPSCs) Preclinical Disease Model Market Size is predicted to grow at an 11.2% CAGR during the forecast period for 2024-2031. Human-induced pluripotent stem cells (hiPSCs) are a pivotal tool in biomedical research, particularly for preclinical disease modelling and drug development. Derived from adult somatic cells like skin or blood cells, hiPSCs are reprogrammed to an embryonic-like pluripote...
Report ID: 2556 |
Delivery: Immediate |
Published: July 2024 |
No. of Pages: 180
VEGFR-1 Inhibitors Market Size is predicted to grow at a 7.0% CAGR during the forecast period for 2024-2031. VEGFR-1 inhibitors are essential in treating various cancers by targeting the vascular endothelial growth factor receptor-1, which is crucial for angiogenesis and tumor growth. The increasing prevalence of cancer and advancements in targeted therapies are expected to drive the adoption of VEGFR-1 inhibitors. Additionally, ongoing resear...
Report ID: 2552 |
Delivery: Immediate |
Published: June 2024 |
No. of Pages: 180
Cephalosporin API Market Size is valued at USD 1.70 billion in 2023 and is predicted to reach USD 2.62 billion by the year 2031 at a 5.7% CAGR during the forecast period for 2024-2031. Cephalosporin APIs are the active pharmaceutical ingredients derived from fungi, specifically Acremonium, and they form the basis of cephalosporin antibiotics like cephalexin and ceftriaxone. These APIs are crucial for treating bacterial infections and undergo r...
Report ID: 2547 |
Delivery: Immediate |
Published: June 2024 |
No. of Pages: 180
Nucleic Acid Therapeutics Market Size is valued at USD 4.93 billion in 2023 and is predicted to reach USD 13.86 billion by the year 2031 at a 13.8% CAGR during the forecast period for 2024-2031. Nucleic acid therapeutics stands for a group of medicinal interventions that prevent illness by means of nucleic acids. Cutting-edge and focused therapies for a broad spectrum of hereditary and chronic diseases are now available through gene-targeting ...
Report ID: 2548 |
Delivery: Immediate |
Published: June 2024 |
No. of Pages: 180
Thymidylate Synthase Inhibitor Market Size is predicted to grow at a 6.0% CAGR during the forecast period for 2024-2031. Thymidylate synthase inhibitors disrupt DNA synthesis by blocking the enzyme thymidylate synthase. They are used primarily in cancer treatment to inhibit the growth of cancer cells, which rely on rapid DNA replication. Examples include 5-fluorouracil (administered intravenously), pemetrexed (also intravenous), and raltitrexe...
Report ID: 2549 |
Delivery: Immediate |
Published: June 2024 |
No. of Pages: 180
cDNA Clone Vectors Market Size is valued at USD 120.8 Mn in 2023 and is predicted to reach USD 258.1 Mn by the year 2031 at a 10.2% CAGR during the forecast period for 2024-2031. cDNA clone vectors are tools used in molecular biology to clone and express complementary DNA (cDNA) derived from messenger RNA (mRNA). These vectors typically contain elements such as promoter regions for gene expression, selection markers for identifying successfull...
Report ID: 2544 |
Delivery: Immediate |
Published: June 2024 |
No. of Pages: 180
Vitamin B12 API Market Size is predicted to grow at a 5.7% CAGR during the forecast period for 2024-2031. Vitamin B12(cobalamin) is a vital vitamin necessary for various important body processes, such as the creation of red blood cells as well as the synthesis of DNA. The API for vitamin B12 refers to the unadulterated form of the vitamin, typically acquired through chemical synthesis or fermentation. The active ingredient is responsible for t...
Report ID: 2536 |
Delivery: Immediate |
Published: June 2024 |
No. of Pages: 179
Non-Viral Transfection Reagents Market Size is valued at USD 649.1 Mn in 2023 and is predicted to reach USD 1,157.5 Mn by the year 2031 at an 7.7% CAGR during the forecast period for 2024-2031. Non-viral transfection reagents represent a significant advancement in genetic manipulation techniques, offering researchers a diverse toolkit for delivering genetic material into cells. Among the several types of non-viral reagents, lipid-based formula...
Report ID: 2533 |
Delivery: Immediate |
Published: June 2024 |
No. of Pages: 180
Thermal Cyclers Market Size is valued at USD 1.03 Bn in 2023 and is predicted to reach USD 1.86 Bn by the year 2031 at an 7.8% CAGR during the forecast period for 2024-2031. Thermal cyclers, also referred to as PCR (Polymerase Chain Reaction) machines or thermocyclers, are laboratory instruments used to amplify segments of DNA via the PCR process. They are essential tools in molecular biology, genetics, and various biological research and medic...
Report ID: 2535 |
Delivery: Immediate |
Published: June 2024 |
No. of Pages: 180
The Anti-aging Therapeutics Market Size is valued at 692.66 Million in 2023 and is predicted to reach 2,527.33 Million by the year 2031 at a 17.62% CAGR during the forecast period for 2024-2031. Anti-aging treatment combines cutting-edge research and medical technology to identify, prevent, cure, and reverse age-related dysfunctions, illnesses, and diseases as early as possible. As a result, anti-aging preventive medicine and heal...
Report ID: 1249 |
Delivery: Immediate |
Published: June 2024 |
No. of Pages: 180
Pharmaceuticals